Impact of infliximab therapeutic drug level monitoring on outcomes of patients with inflammatory bowel disease: A real-world experience from a Middle Eastern cohort

Nahla Azzam; Abdulrahman Aljebreen; Othman Alharbi; Aline Charabaty; Mohammed Alanazi; Nashmi Alkuwaykibi; Jowaher Alfaraidi; Ahmad Bashamil; Tarik Almansour; Majid Almadi

doi:10.1016/j.ajg.2021.01.001

Q2 2021

Impact of infliximab therapeutic drug level monitoring on outcomes of patients with inflammatory bowel disease: A real-world experience from a Middle Eastern cohort

Nahla Azzam · Abdulrahman Aljebreen · Othman Alharbi · Aline Charabaty · Mohammed Alanazi · Nashmi Alkuwaykibi · Jowaher Alfaraidi · Ahmad Bashamil · Tarik Almansour · Majid Almadi

10.1016/j.ajg.2021.01.001 390 المشاهدات 3 الاقتباسات

الاقتباسات

390

المشاهدات

الملخص غير متوفر لهذا المنشور.

الاستشهاد بهذا المقال (APA)

Nahla, A., Abdulrahman, A., Othman, A., Aline, C., Mohammed, A., Nashmi, A., Jowaher, A., Ahmad, B., Tarik, A., Majid, A. (2021). Impact of infliximab therapeutic drug level monitoring on outcomes of patients with inflammatory bowel disease: A real-world experience from a Middle Eastern cohort. Arab Journal of Gastroenterology. https://doi.org/10.1016/j.ajg.2021.01.001

Jamil S. Samaan; Yee Hui Yeo; Wee Han Ng; Peng-Sheng Ting; Hirsh Trivedi; Aarshi · 2023

استشهاد

390

Performance of FibroScan in grading steatosis and fibrosis in patients with nonalcoholic fatty liver…

Xiaotong Xu; Jinglan Jin; Yuwei Liu · 2023

استشهاد

394

Synthesis and characterization of amoxicillin-loaded polymeric nanocapsules as a drug delivery syste…

Aya Abdelghany; Mohamed A. El-Desouky; Mohamed Shemis · 2021

استشهاد

388

Short-term orlistat therapy improves fatty infiltration indices and liver fibrosis scores in patient…